American International Group’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

American International Group’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1	Closed	-$2.8K	–	5087
2015 Q2	$2.8K	Hold	1	–	–	﹤0.01%	4851
2015 Q1	$3.78K	Hold	1	–	–	﹤0.01%	4751
2014 Q4	$4.2K	Hold	1	–	–	﹤0.01%	4725
2014 Q3	$4.48K	Buy	+1	New	+$3.89K	﹤0.01%	4719
2014 Q2	–	Sell	-16	Closed	-$66.6K	–	5050
2014 Q1	$66.6K	Hold	16	–	–	﹤0.01%	3708
2013 Q4	$59.5K	Hold	16	–	–	﹤0.01%	3695
2013 Q3	$63.6K	Sell	16 -1	-6%	-$7.5K	﹤0.01%	3609
2013 Q2	$164K	Buy	+17	New	+$188K	﹤0.01%	2744

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SGAM

Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

American International Group's FRTX Position: Q3 2015 in Review

American International Group sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2015, closing a stake of 1 share — an estimated $2.8K sold.

American International Group first reported a position in FRTX in Q2 2013 and held it in 8 quarters. The position peaked at $164K in Q2 2013. 49 funds tracked by Wall St. Rank hold FRTX as of Q3 2015.

American International Group reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
American International Group sold 1 Fresh Tracks Therapeutics, Inc. Common Stock share in Q3 2015, an estimated $2.8K.
American International Group first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 8 quarters.
American International Group's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $164K in Q2 2013.
49 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2015.

Based on American International Group's 13F filing for Q3 2015, filed 12 Nov 2015.